Navigation Links
Results of NeuroThera Effectiveness and Safety Trial - 2 (NEST-2) Presented at International Stroke Conference 2009
Date:2/20/2009

sham group. This 9.7% treatment effect was statistically significant (p-value 0.044).

"TLT is one of the most promising new therapies that we've seen in a long time, especially as it may expand the treatment window for ischemic stroke to 24 hours. We look forward to commencing NEST-3 to further investigate TLT," stated Professor Werner Hacke, M.D., Ph.D., Chairman of Neurology at the University of Heidelberg, who will join Professor Zivin as Co-Chairman of the NEST-3 Steering Committee.

About Acute Ischemic Stroke

According to the American Stroke Association, stroke is the third leading cause of death in the United States. Ischemic stroke, which accounts for about 83 percent of all strokes, occurs as a result of an obstruction within a blood vessel supplying blood to the brain.

About PhotoThera

PhotoThera, Inc. (www.photothera.com), located in Carlsbad, CA, is developing transcranial laser therapy (TLT) for the treatment of acute ischemic stroke and other neurological diseases and disorders. The company was founded by Jackson Streeter, M.D., a former U.S. Navy flight surgeon and TOPGUN instructor.


'/>"/>
SOURCE PhotoThera, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
3. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
4. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
5. Tapestry Reports Second Quarter 2007 Results
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
8. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
9. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
10. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... May 22, 2013  Viral hepatitis is an asymptomatic disease ... of those with hepatitis C are unaware they have the ... Awareness Day in the U.S. House of Representatives will take ... Foyer of the Rayburn House Office Building in ... for the Study of Liver Diseases ( AASLD ) is ...
(Date:5/22/2013)... WHITE PLAINS, N.Y. , May 22, 2013 /PRNewswire/ ... $6 million to Valor Biotherapeutics, LLC, a ... completion of pre-clinical development, manufacturing, and a Phase I ... change the poor outcomes faced by many patients with ... with rituximab. Valor,s protein, IGN002, is ...
(Date:5/22/2013)... CAESAREA, Israel , May 22, 2013 ... clinical data presented from the DEFLECT-I study demonstrates that ... brain lesion volume during TAVR (Transcatheter Aortic Valve Replacement) ... Heart Scientific Advisory Board announces consensus on the importance ... the importance and need for cerebral protection during cardiovascular ...
Breaking Medicine Technology:Hepatitis Awareness: Bringing Attention to a Silent Epidemic 2The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 2The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 3The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 4New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 2New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 3New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 4
... BETHESDA, Md. , July 22 At two Food ... Vice President, Pharmaceutical Risk Management Services of Pinney ... ensure that Risk Evaluation and Mitigation Strategies (REMS) benefit patient safety ... , ...
... , WOODCLIFF LAKE, N.J. , July 22 Par ... Patrick J. Zenner has been elected to the company,s board of ... Committee and the Corporate Development Review Committee.   , ... Mr. Zenner retired in January 2001 ...
Cached Medicine Technology:Expert Challenges FDA to Bring Predictability, Feasibility, and Transparency to Drug Risk Management Process 2Patrick J. Zenner Elected to Board of Directors of Par Pharmaceutical Companies, Inc. 2
(Date:5/22/2013)... May 22, 2013 Hurricane preparation isn’t ... home. That’s why Amica Insurance is reminding ... the upcoming hurricane season. , “An important part of ... Cook, a senior assistant vice president at Amica Insurance. ... before the threat of a storm.” , Flood damage ...
(Date:5/22/2013)... trustworthy, loving child care is one of the most important ... parents in their search, Paty’s Daycare has launched a ... staff and much more. , “Our new website is vibrant, ... Patricia “Auntie Paty” Sutton, founder of Paty’s Daycare. “Just as ... from the first time that you walk through the front ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 Unknown to the ... area at 30 mph. Minutes before it struck, the ... the nearing threat. This gave them time to reach safety ... Data is proud to provide a product that will ... A Wheelock SAFEPATH® SP40S Emergency Evacuation System provides ...
(Date:5/22/2013)... HealthDay Reporter , , WEDNESDAY, May 22 (HealthDay News) -- ... who die each year awaiting an organ donation dropped ... numbers of children are receiving donor organs. During ... expanded to include not just patients who,ve experienced brain ... death." But it,s unclear how much that shift ...
(Date:5/22/2013)... oil supplements could help reduce the risk for ... The supplements, also known as omega-3 fatty acids, ... linked to insulin sensitivity, Harvard researchers found. Higher ... also been linked to a lower risk for ... fish oil increased circulating adiponectin, whether similar effects ...
Breaking Medicine News(10 mins):Health News:Reviewing Insurance Policies: a Key Part of Hurricane Preparations 2Health News:Paty’s Daycare Launches New Website to Connect with Parents in Need of Nurturing Child Care 2Health News:Telcom & Data Introduces Wheelock SAFEPATH® SP40S Emergency Evacuation System, An Effective Office Tool to Protect Employees from Severe Weather Threats 2Health News:More Kids Getting Donor Organs, But Gaps Persist, Study Finds 2Health News:More Kids Getting Donor Organs, But Gaps Persist, Study Finds 3Health News:More Kids Getting Donor Organs, But Gaps Persist, Study Finds 4Health News:Fish Oil Pills Might Cut Diabetes Risk, Researchers Say 2
... Heart attacks in women go largely unrecognized 30 to ... warning signs and fail or delay getting help, run the ... University and SUNY Upstate Medical University have developed an educational ... ultimately, save lives. Women often don,t have the same ...
... (HealthDay News) -- Two-thirds of driving-age American teens with ... plan to drive, and these teens have a number ... with high-functioning autism spectrum disorders, or HFASDs, have subtle ... They also have difficulty regulating emotions. Many of ...
... (Jan. 12, 2012) Using two cell ... breast cancer lymph node metastases, researchers at Moffitt ... have developed targeted, fluorescent molecular imaging probes that ... The new procedure could spare breast cancer patients ...
... how the brain reconfigures its connections to minimize distractions and ... order to behave efficiently, you want to process relevant sensory ... your current situation," said Joy Geng, assistant professor of psychology ... For example, a flashing road sign alerts us to traffic ...
... , THURSDAY, Jan. 12 (HealthDay News) -- The ... HIV-infected person is the single most important risk factor for ... study of heterosexual couples has found. The research, published ... , also confirmed that the use of condoms significantly reduces ...
... enrollees cost them less, Medicare Advantage plans would profit ... strictly forbids practices such as denying coverage based on ... membership is to design insurance benefits that attract the ... 12, 2012, edition of the New England Journal ...
Cached Medicine News:Health News:Educating women about heart attacks could save lives 2Health News:Educating women about heart attacks could save lives 3Health News:Little Known About How Autism Affects Teen Drivers: Researchers 2Health News:Researchers find new, noninvasive way to identify lymph node metastasis 2Health News:Partner's 'Viral Load' a Major Factor in HIV Transmission: Study 2Health News:Gym benefits help Medicare plans recruit healthy seniors 2Health News:Gym benefits help Medicare plans recruit healthy seniors 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: